The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up. The Centers for Disease Control and ...
Hosted on MSN
Novavax COVID-19 vaccine to get full approval
The Novavax COVID-19 vaccine is set to finally receive full approval from the FDA. The agency said Novavax must collect more clinical data from people who received that vaccine in order to get full ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Shares of vaccine makers fell Monday after the Food and Drug Administration’s top vaccine regulator said in an internal memo that the agency would introduce stricter vaccine approval rules. In an ...
Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official claimed the shots led to 10 children’s deaths and said the agency would tighten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results